中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
31期
39-40,41
,共3页
王洪云%疏云%吴燕玲%陶黎明%胡贤春
王洪雲%疏雲%吳燕玲%陶黎明%鬍賢春
왕홍운%소운%오연령%도려명%호현춘
三维适形%放疗%FOLFOX4%淋巴结转移癌
三維適形%放療%FOLFOX4%淋巴結轉移癌
삼유괄형%방료%FOLFOX4%림파결전이암
Three-dimensional conformal%Radiotherapy%FOLFOX4%Lymph node metastasis carcinoma
目的:比较不同方案治疗术后腹膜后恶性淋巴结转移癌的临床疗效差异。方法:选取本院收治的58例消化道恶性肿瘤术后发生腹膜后恶性淋巴结转移癌的患者,分为对照组(FOLFOX4方案单纯化疗)和观察组(三维适形放疗同步FOLFOX4方案),比较两组肿瘤控制率、KPS评分、不良反应发生率和远期生存率的差异。结果:观察组肿瘤控制率为82.8%,显著高于对照组的62.1%,观察组KPS评分显著高于对照组,观察组累积生存率和平均生存期均显著高于对照组,比较差异有统计学意义(P<0.05);两组患者不良反应发生率比较差异无统计学意义(P>0.05)。结论:三维适形放疗同步FOLFOX4方案治疗术后腹膜后恶性淋巴结转移癌效果确切,有利于肿瘤的控制,近远期疗效均好。
目的:比較不同方案治療術後腹膜後噁性淋巴結轉移癌的臨床療效差異。方法:選取本院收治的58例消化道噁性腫瘤術後髮生腹膜後噁性淋巴結轉移癌的患者,分為對照組(FOLFOX4方案單純化療)和觀察組(三維適形放療同步FOLFOX4方案),比較兩組腫瘤控製率、KPS評分、不良反應髮生率和遠期生存率的差異。結果:觀察組腫瘤控製率為82.8%,顯著高于對照組的62.1%,觀察組KPS評分顯著高于對照組,觀察組纍積生存率和平均生存期均顯著高于對照組,比較差異有統計學意義(P<0.05);兩組患者不良反應髮生率比較差異無統計學意義(P>0.05)。結論:三維適形放療同步FOLFOX4方案治療術後腹膜後噁性淋巴結轉移癌效果確切,有利于腫瘤的控製,近遠期療效均好。
목적:비교불동방안치료술후복막후악성림파결전이암적림상료효차이。방법:선취본원수치적58례소화도악성종류술후발생복막후악성림파결전이암적환자,분위대조조(FOLFOX4방안단순화료)화관찰조(삼유괄형방료동보FOLFOX4방안),비교량조종류공제솔、KPS평분、불량반응발생솔화원기생존솔적차이。결과:관찰조종류공제솔위82.8%,현저고우대조조적62.1%,관찰조KPS평분현저고우대조조,관찰조루적생존솔화평균생존기균현저고우대조조,비교차이유통계학의의(P<0.05);량조환자불량반응발생솔비교차이무통계학의의(P>0.05)。결론:삼유괄형방료동보FOLFOX4방안치료술후복막후악성림파결전이암효과학절,유리우종류적공제,근원기료효균호。
Objective:To compare clinical efficacy of different treatment for postoperative malignant retroperitoneal lymph node metastasis carcinoma. Method:58 cases with retroperitoneal lymph node metastases after resection of gastrointestinal cancer surgery in our hospital were randomly divided into control group(treated with FOLFOX4)and observation group(treated with three-dimensional conformal radiotherapy synchronous FOLFOX4). The tumor control rate,KPS score,adverse reactions rate and long-term survival rate of two groups were compared. Result:Tumor control rate of observation group was 82.8%,which was significantly higher than 62.1% of the control group (P<0.05). KPS score of observation group was significantly higher than that of the control group(P<0.05). Adverse reactions rate of the two groups had no significant difference(P>0.05). Cumulative survival rate and mean survival time of observation group were significantly higher than that of the control group(P<0.05). Conclusion:Three-dimensional conformal radiotherapy synchronous FOLFOX4 for postoperative malignant retroperitoneal lymph node metastasis carcinoma has exact effect with a high near-term effect. It’s conducive to tumor control.